Raynaud Phenomenon
Showing 26 - 50 of 1,320
Tadalafil-Delivra and Raynaud's Phenomenon
Withdrawn
- Raynaud Phenomenon
- Observation of treatment with Tadalafil-Delivra
-
Hamilton, Ontario, Canada
- +1 more
Sep 18, 2018
Systemic scleRosis and Progressive Digital ulcEr Disease.
Recruiting
- Scleroderma
- +4 more
-
Athens, GreeceLaikon Hospital of Athens
Mar 22, 2022
Ulcer, Acral Nevus, Scleroderma Trial in Firenze (EmoLED treatment, current Standard of Care)
Recruiting
- Ulcer
- +3 more
- EmoLED treatment
- current Standard of Care
-
Firenze, ItalyAOU Careggi - SOD Reumatologia - Scleroderma Unit
Apr 29, 2022
Scleroderma, Calcinosis Cutis Trial (Extracorporeal Shock Wave Therapy (ESWT), PNF)
Not yet recruiting
- Scleroderma
- Calcinosis Cutis
- Extracorporeal Shock Wave Therapy (ESWT)
- PNF
- (no location specified)
May 12, 2023
Systemic Sclerosis, 7.0 Tesla Magnetic Resonance Imaging, Hand Vascular Involvement Trial (7.0 T RMI)
Not yet recruiting
- Systemic Sclerosis
- +3 more
- 7.0 T RMI
- (no location specified)
Jan 28, 2021
Scleroderma Trial in Pittsburgh (atorvastatin, Placebo)
Completed
- Scleroderma
- atorvastatin
- Placebo
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh
Aug 10, 2020
Raynaud Disease, Raynaud's Phenomenon Trial in London (Manual blood pressure cuff inflation over brachial artery)
Completed
- Raynaud Disease
- Raynaud's Phenomenon
- Manual blood pressure cuff inflation over brachial artery
-
London, Ontario, CanadaRheumatology Clinic, St. Joseph's Health Care
Aug 7, 2018
Scleroderma, Systemic, Scleroderma, Diffuse, Sclerosis, Systemic Trial in Adelaide, Fitzroy (FT011, Placebo)
Active, not recruiting
- Scleroderma, Systemic
- +2 more
- FT011
- Placebo
-
Adelaide, South Australia, Australia
- +1 more
Jul 20, 2022
The Clinical Course of Interstitial Pneumonia With Autoimmune
Recruiting
- Interstitial Pneumonia
-
London, Ontario, CanadaLondon Health Science Centre
Apr 5, 2022
Scleroderma, Systemic Trial in Worldwide (BI 685509, Placebo)
Recruiting
- Scleroderma, Systemic
- BI 685509
- Placebo
-
Liverpool, New South Wales, Australia
- +25 more
Jan 27, 2023
Sjogren Syndrome, Mixed Connective Tissue Disease Trial in Worldwide (MHV370, Placebo)
Recruiting
- Sjogren Syndrome
- Mixed Connective Tissue Disease
- MHV370
- Placebo
-
Guangzhou, Guangdong, China
- +18 more
Jul 29, 2022
Systemic Sclerosis Trial in Ankara (Cognitive Exercise Therapy Approach (BETY))
Active, not recruiting
- Systemic Sclerosis
- Cognitive Exercise Therapy Approach (BETY)
-
Ankara, TurkeyHacettepe University
Jul 12, 2022
Systemic Sclerosis Trial in Brest, Rennes, Tours (Minor Salivary gland Biopsy, ARFI, MSG US)
Completed
- Systemic Sclerosis
- Minor Salivary gland Biopsy
- +2 more
-
Brest, France
- +2 more
Apr 4, 2022
Systemic Sclerosis, Scleroderma, Diffuse Systemic Sclerosis Trial in Scottsdale (Ixazomib)
Recruiting
- Systemic Sclerosis
- +18 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
May 3, 2022
Systemic Sclerosis Trial in Denizli (ozone therapy)
Completed
- Systemic Sclerosis
- ozone therapy
-
Denizli, TurkeyPamukkale Unıversity
Jan 22, 2022
Raynaud Disease, Systemic Sclerosis, Digital Ulcer Trial in Seoul (Calcium Channel Blockers, Phosphodiesterase Inhibitors,
Terminated
- Raynaud Disease
- +2 more
- Calcium Channel Blockers
- +4 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Nov 8, 2020
Systemic Sclerosis Trial in Sheffield (Exercise programme)
Recruiting
- Systemic Sclerosis
- Exercise programme
-
Sheffield, United KingdomSheffield Hallam University
Jul 19, 2022
Systemic Sclerosis-Associated PAH Trial in United States (biological, other, diagnostic test, drug)
Completed
- Systemic Sclerosis-Associated PAH
- Rituximab
- +6 more
-
Stanford, California
- +16 more
Mar 3, 2021
Scleroderma, Systemic Sclerosis Trial in Bordeaux (Blood samples, Biopsy, Bronchoalveolar samples)
Recruiting
- Scleroderma
- Systemic Sclerosis
- Blood samples
- +2 more
-
Bordeaux, FranceCHU de Bordeaux - service de rhumatologie
May 6, 2021
Systemic Sclerosis, Calcinosis Trial in Palo Alto (Oral treprostinil)
Completed
- Systemic Sclerosis
- Calcinosis
- Oral treprostinil
-
Palo Alto, CaliforniaStanford University School of Medicine
Jun 8, 2021
Lung Diseases, Interstitial, Fibrosis Lung Trial in Trabzon
Active, not recruiting
- Lung Diseases, Interstitial
- Fibrosis Lung
-
Trabzon, TurkeyDepartment Of Chest Diseases, School Of medicine, Karadeniz Tech
Mar 4, 2021
Scleroderma, Systemic, Sclerosis, Systemic Trial in London (Interstitial lung disease induction algorithm, Pulmonary arterial
Unknown status
- Scleroderma, Systemic
- Sclerosis, Systemic
- Interstitial lung disease induction algorithm
- +9 more
-
London, Ontario, CanadaSaint Joseph's Health Care London
Aug 2, 2018
Peripheral Neuropathy Due to Chemo Trial in Milwaukee (IncobotulinumtoxinA (Xeomin®, Merz) (INA), Normal saline)
Recruiting
- Peripheral Neuropathy Due to Chemotherapy
- IncobotulinumtoxinA (Xeomin®, Merz) (INA)
- Normal saline
-
Milwaukee, WisconsinFroedtert Hospital
Dec 21, 2021
Systemic Sclerosis Patients With Digital Ulcers Trial in Showa (Botulinum toxin type B (2500 units / vial), Physiological
Completed
- Systemic Sclerosis Patients With Digital Ulcers
- Botulinum toxin type B (2500 units / vial)
- Physiological saline
-
Showa, Gunma, JapanGunma University Graduate school of Medicine
May 12, 2020